Development of strategic plan covering business and functional strategies that are updated on an annual basis
Development of M&A strategy and identification of potential acquisition opportunities
​
Buy-side support for the acquisition of Avivia BV, a leading CRO focused on formulation development services based in the Netherlands
Buy-side support for the acquisition of Recipharm Uppsala AB, Sweden focused on bioconjugation, ADCs and oligonoculetides
Development of growth strategy, business plan preparation support, indicative valuation, selection, and approach of potential investors and collaboration partners
Strategic support for m-RNA vaccine manufacturing ramp-up
Acquisition of Ardena, a specialist pharmaceutical Contract Development and Manufacturing Organisation (CDMO) based in the Netherlands
Divestment of API manufacturing facility in Mahad, India to Olon
Divestment of manufacturing site for sterile drug product fill & finish (FDF) located in Basel, Switzerland to Lonza
Development and implementation of strategic planning process
​
Acquisition of UK based Fine Organics from North Edge Capital
Development of business plan, indicative valuation, investor presentation, approach of outside US licensing partners